Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products in orthopedics, sports medicine and wound care, announced today that, on November 27, 2013, the Centers for Medicare and Medicaid Services released their proposed ruling for the reimbursement of skin substitutes in the hospital outpatient setting.
http://www.businesswire.com/news/topix/20131129005345/en
http://www.businesswire.com/news/topix/20131129005345/en
No comments:
Post a Comment